Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Aug 27, 2021 2:35pm
176 Views
Post# 33776630

RE:RE:RE:Be prepared.

RE:RE:RE:Be prepared.Just shut up. You flip flop more than a fish out of water.

I’m sure “after much research” you’ll be back to bash. Rinse and repeat. 

Anymore car pics you want share, incel? LOL! 

Rarbar99 wrote:

You mean when I was constantly telling y'all to sell at $1.40-$1.50 3 weeks ago?

and then I told y'all to buy at $1.15 last week?

like it or not, my predictions have been very accurate.

And I'm not saying it will go below sub $1, I'm just saying it's very possible. I won't be surprised if it does.

 

IrishCanuck wrote:

 

"I better say a lot of prices because if I hit one I can seem prophetic" 

 

Rarbar99 wrote:

 

Although I'm bullish on this company in the long run. Expect a drop to 0.80-0.90 as early as next month. And a possible crash down to 0.60 depending on how October's report will go. 

It is what it is, these numbers are all very real possibilities. DCA if you're bullish but please don't think for a second that we've bottomed out. We can still drop another 50% from here.


 




<< Previous
Bullboard Posts
Next >>